Rhinovirus/enterovirus was the most common respiratory virus detected in adults with severe acute respiratory infections pre-COVID-19 in Kuala Lumpur, Malaysia.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2022
2022
Historique:
received:
29
05
2022
accepted:
14
08
2022
entrez:
2
9
2022
pubmed:
3
9
2022
medline:
9
9
2022
Statut:
epublish
Résumé
Severe acute respiratory infections (SARI) pose a great global burden. The contribution of respiratory viruses to adult SARI is relatively understudied in Asia. We aimed to determine viral aetiology of adult SARI patients in Kuala Lumpur, Malaysia. The prevalence of 20 common (mainly viral) respiratory pathogens, and MERS-CoV, SARS-CoV and 5 bacterial select agents was investigated from May 2017 to October 2019 in 489 SARI adult patients in Kuala Lumpur, Malaysia, using molecular assays (Luminex NxTAG-RPP kit and qPCR assays). Viral metagenomics analysis was performed on 105 negative samples. Viral respiratory pathogens were detected by PCR in 279 cases (57.1%), including 10 (2.0%) additional detections by metagenomics analysis. The most detected viruses were rhinovirus/enterovirus (RV/EV) (49.1%) and influenza virus (7.4%). Three melioidosis cases were detected but no SARS-CoV, MERS-CoV or other bacterial select agents. Bacterial/viral co-detections and viral co-detections were found in 44 (9.0%) and 27 (5.5%) cases respectively, mostly involving RV/EV. Independent predictors of critical disease were male gender, chronic lung disease, lack of runny nose and positive blood culture with a significant bacterial pathogen. Asthma and sore throat were associated with increased risk of RV/EV detection, while among RV/EV cases, males and those with neurological disease were at increased risk of critical disease. Prior to the COVID-19 pandemic, the high prevalence of respiratory viruses in adults with SARI was mainly attributed to RV/EV. Continued surveillance of respiratory virus trends contributes to effective diagnostic, prevention, and treatment strategies.
Sections du résumé
BACKGROUND
Severe acute respiratory infections (SARI) pose a great global burden. The contribution of respiratory viruses to adult SARI is relatively understudied in Asia. We aimed to determine viral aetiology of adult SARI patients in Kuala Lumpur, Malaysia.
METHODS
The prevalence of 20 common (mainly viral) respiratory pathogens, and MERS-CoV, SARS-CoV and 5 bacterial select agents was investigated from May 2017 to October 2019 in 489 SARI adult patients in Kuala Lumpur, Malaysia, using molecular assays (Luminex NxTAG-RPP kit and qPCR assays). Viral metagenomics analysis was performed on 105 negative samples.
RESULTS
Viral respiratory pathogens were detected by PCR in 279 cases (57.1%), including 10 (2.0%) additional detections by metagenomics analysis. The most detected viruses were rhinovirus/enterovirus (RV/EV) (49.1%) and influenza virus (7.4%). Three melioidosis cases were detected but no SARS-CoV, MERS-CoV or other bacterial select agents. Bacterial/viral co-detections and viral co-detections were found in 44 (9.0%) and 27 (5.5%) cases respectively, mostly involving RV/EV. Independent predictors of critical disease were male gender, chronic lung disease, lack of runny nose and positive blood culture with a significant bacterial pathogen. Asthma and sore throat were associated with increased risk of RV/EV detection, while among RV/EV cases, males and those with neurological disease were at increased risk of critical disease.
CONCLUSIONS
Prior to the COVID-19 pandemic, the high prevalence of respiratory viruses in adults with SARI was mainly attributed to RV/EV. Continued surveillance of respiratory virus trends contributes to effective diagnostic, prevention, and treatment strategies.
Identifiants
pubmed: 36054088
doi: 10.1371/journal.pone.0273697
pii: PONE-D-22-15536
pmc: PMC9439195
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, Non-P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0273697Subventions
Organisme : NINR NIH HHS
ID : R01 NR009547
Pays : United States
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Braz J Microbiol. 2012 Oct;43(4):1641-5
pubmed: 24031996
Front Microbiol. 2019 Dec 03;10:2737
pubmed: 31849887
J Infect Dis. 2016 Feb 15;213(4):584-91
pubmed: 26180044
Mol Cell Probes. 2011 Feb;25(1):8-12
pubmed: 20933595
BMC Infect Dis. 2021 Jul 5;21(1):644
pubmed: 34225647
BMC Pediatr. 2012 Mar 20;12:32
pubmed: 22429933
Front Microbiol. 2018 Aug 07;9:1836
pubmed: 30131797
Pediatrics. 2014 Mar;133(3):e538-45
pubmed: 24567027
Gigascience. 2020 Oct 15;9(10):
pubmed: 33057676
J Infect. 2020 Aug;81(2):e62-e64
pubmed: 32360499
Clin Chem. 2004 Jan;50(1):67-72
pubmed: 14709637
Respir Res. 2019 Sep 13;20(1):210
pubmed: 31519188
BMC Biol. 2014 Nov 12;12:87
pubmed: 25387460
Genome Res. 2019 May;29(5):831-842
pubmed: 30992304
Open Forum Infect Dis. 2019 Feb 13;6(3):ofz074
pubmed: 30949525
J Clin Virol. 2021 Dec;145:105000
pubmed: 34739838
Am J Trop Med Hyg. 2014 Dec;91(6):1176-8
pubmed: 25246695
Am J Trop Med Hyg. 2016 Aug 3;95(2):339-47
pubmed: 27246444
Virology. 2017 Sep;509:159-166
pubmed: 28646651
Euro Surveill. 2012 Sep 27;17(39):
pubmed: 23041020
J Clin Virol. 2022 Apr;149:105126
pubmed: 35299101
J Clin Virol. 2015 May;66:83-9
pubmed: 25866344
Clin Vaccine Immunol. 2015 Sep 16;23(1):6-10
pubmed: 26376925
Lancet Respir Med. 2019 Jan;7(1):69-89
pubmed: 30553848
J Med Microbiol. 2020 Jan;69(1):49-51
pubmed: 31750812
J Infect Dis. 2020 Oct 7;222(Supplement_7):S563-S569
pubmed: 30849176
J Clin Microbiol. 2019 Aug 26;57(9):
pubmed: 31217274
J Clin Microbiol. 2003 Dec;41(12):5492-9
pubmed: 14662930
J Med Virol. 2019 Mar;91(3):498-502
pubmed: 30199092
BMC Res Notes. 2018 Feb 09;11(1):120
pubmed: 29426368
J Clin Microbiol. 2011 Jul;49(7):2631-6
pubmed: 21543571
BMC Microbiol. 2006 Jan 19;6:2
pubmed: 16423303
J Clin Virol. 2016 Nov;84:59-63
pubmed: 27723525
JAMA Netw Open. 2021 Jan 4;4(1):e2035281
pubmed: 33492377
J Paediatr Child Health. 2018 Dec;54(12):1321-1328
pubmed: 29873433
J Clin Microbiol. 2006 Aug;44(8):2698-704
pubmed: 16891480
J Clin Microbiol. 2006 Jan;44(1):85-90
pubmed: 16390953
Intervirology. 2015;58(1):57-68
pubmed: 25890989